comparemela.com
  1. Home
  2. Live Updates
  3. Demonstrating Long Term Safety - Breaking News

Latest Breaking News On - Demonstrating long term safety - Page 1 : comparemela.com

Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc

First-Quarter 2021 Net Sales of $342.4 Million; First-Quarter 2021 GAAP Net Loss of $123.4 Million; Adjusted EBITDA of $45.8 Million First-Quarter 2021 Orphan Segment Net Sales Increased

United statesViela bioRuth venningGeoff curtisTim walbertTina venturaNeuroimmunology neuroinflammationRay gordonDevelopment pipelineReddy laboratoryViela bio incSubcutaneous administrationKey clinical development programsCompanies to workResearch in multiple sclerosisAmerican committee for treatment

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.